Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duration of Treatment With TKIs in the Treatment of Metastatic Renal Cell Carcinoma

NCT01585974 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01585974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01585974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duration of Treatment With TKIs in the Treatment of Metastatic Renal Cell Carcinoma
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
October 31, 2012
Completion date
November 30, 2015
Enrollment
151 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma